Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Wave Life Sci Ord Sh (WVE)

Wave Life Sci Ord Sh (WVE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Wave Life Sciences to Present at 43rd Annual J.P. Morgan Healthcare Conference

WVE : 13.51 (+2.43%)
Insider Sale: President and CEO of $WVE (WVE) Sells 50,000 Shares

PAUL BOLNO, the President and CEO of $WVE ($WVE), sold 50,000 shares of the company on 11-25-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 18.7% of their...

WVE : 13.51 (+2.43%)
Wave Life Sciences to Present at Upcoming Investor Conferences

WVE : 13.51 (+2.43%)
Wave Life Sciences CEO to Participate in Analyst-led Fireside Chat at Jefferies London Healthcare Conference

Wave Life Sciences CEO Paul Bolno will speak at the Jefferies London Healthcare Conference on November 20, 2024.Quiver AI SummaryWave Life Sciences Ltd. announced that CEO Paul Bolno will participate in...

WVE : 13.51 (+2.43%)
Wave Life Sciences to Present at Jefferies London Healthcare Conference

WVE : 13.51 (+2.43%)
Wave Life Sciences: Q3 Earnings Snapshot

Wave Life Sciences: Q3 Earnings Snapshot

WVE : 13.51 (+2.43%)
Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update

WVE : 13.51 (+2.43%)
Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024

WVE : 13.51 (+2.43%)
Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs

WVE : 13.51 (+2.43%)
1 Brand-New Big Reason to Buy This Biotech Stock Right Now

This stock currently has a good balance of risk and potential rewards.

WVE : 13.51 (+2.43%)

Barchart Exclusives

How To Profit From The Latest Corporate Spinoffs: A Guide For Investors In 2025
How to navigate corporate spinoffs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar